Finance

Beta
Lists
539871:BOM
Thyrocare Technologies Ltd
₹536.05
+0.55%
(+2.95) 1D
Jun 17, 11:51:23 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539871...
Open
₹539.75
High
₹539.75
Low
₹533.10
Mkt. cap
85.63B
Avg. vol.
55.31K
Volume
2.65K
Dividend
1.74%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
52.48
52-wk high
₹578.05
52-wk low
₹316.77
EPS
₹10.21
Shares outstanding
52.76M
No. of employees
2K
Open
₹539.75
High
₹539.75
Low
₹533.10
Mkt. cap
85.63B
Avg. vol.
55.31K
Volume
2.65K
Dividend
1.74%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
52.48
52-wk high
₹578.05
52-wk low
₹316.77
EPS
₹10.21
Shares outstanding
52.76M
No. of employees
2K
News stories
From sources across the web
Profile
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
About Thyrocare Technologies Ltd
CEO-
Employees1.91K
Founded1996
HeadquartersNavi Mumbai, Maharashtra, India
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.93B
2.17B
1.96B
2.24B
Cost of goods sold
886.30M
932.90M
829.60M
1.17B
Cost of revenue
886.30M
932.90M
829.60M
1.17B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
292.50M
Operating expense
580.40M
634.00M
763.70M
460.70M
Total operating expenses
1.47B
1.57B
1.59B
1.63B
Operating income
463.60M
598.40M
362.00M
613.70M
Other non operating income
46.50M
30.50M
50.70M
-112.20M
EBT including unusual items
504.80M
625.80M
353.90M
644.30M
EBT excluding unusual items
504.80M
625.80M
415.50M
525.80M
Income tax expense
121.90M
147.70M
73.40M
157.30M
Effective tax rate
24.15%
23.60%
20.74%
24.41%
Other operating expenses
466.30M
518.90M
547.40M
-126.20M
Net income
389.30M
479.90M
290.10M
471.10M
Net profit margin
20.17%
22.16%
14.84%
21.04%
Earnings per share
2.44
-
2.11
2.98
Interest and investment income
-
-
-
34.00M
Interest expense
-7.80M
-5.90M
-
-15.20M
Net interest expenses
-7.80M
-5.90M
-
18.80M
Depreciation and amortization charges
114.10M
115.10M
216.30M
140.30M
EBITDA
579.35M
713.00M
477.75M
711.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more